share_log
Breakings ·  05:20
Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination From the Mythic Phase 1 Gynecologic Expansion Clinical Trial
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment